✨ Free AI Report
Vivani Medical, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Vivani Medical, Inc.
Company Research

Vivani Medical, Inc.: Business Overview, Financials & Competitive Analysis

Vivani Medical is a clinical-stage biopharmaceutical company developing miniaturized and subdermal drug implants using its proprietary NanoPortal implant technology to address chronic diseases and medication non-adher...

Analyst-debate audio for Vivani Medical, Inc.

AskCyborg analysts argue the bull and bear cases for Vivani Medical, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
5/ 10Mixed

Cyborg Score thesis

NanoPortal implant technology offers transformative potential in chronic disease management if clinical trials succeed, but...

Read the full analyst-debate transcript →
Industry Biopharmaceutical/Medical Devices - Drug Delivery Systems
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Vivani Medical, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Vivani Medical, Inc. Overview

Pro stress-test →

Vivani Medical is a clinical-stage biopharmaceutical company developing miniaturized and subdermal drug implants using its proprietary NanoPortal implant technology to address chronic diseases and medication non-adherence. The company is pursuing a pivotal opportunity in obesity/weight management by developing ultra long-acting implants that deliver therapy for six months or longer with a single administration.

Strategic Profile

Pro stress-test →

Formed in August 2022 through a merger of Second Sight Medical Products and Nano Precision Medical, Vivani inherited neurostimulation assets and NPM's NanoPortal drug implant technology, with a strategic pivot to prioritize the Biopharm pipeline. The company announced the spin-off of Cortigent, its wholly-owned subsidiary developing brain implant devices with cutting-edge neuromodulation technology.

Competitive Landscape

Pro stress-test →

Vivani's GLP-1 implant candidates aim to deliver the same active ingredients as market leaders like Ozempic, Trulicity, and Wegovy through an implant format. Competitors include established injectable GLP-1 providers (Novo Nordisk, Eli Lilly), long-acting GLP-1 formulations in development, and other implant-based delivery platforms targeting chronic disease adherence.

Industry Context

Vivani Medical, Inc. operates in Biopharmaceutical/Medical Devices - Drug Delivery Systems.

Key facts

Founded: 2022 · Headquarters: Alameda, CA, United States · Market cap: $78.2M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Vivani Medical, Inc..

  • Lead drug implant candidates are designed to improve medication adherence and deliver smooth consistent therapeutic levels of GLP-1 for six months or longer with a single administration.
  • NPM-115 and NPM-119 are miniature, six-month GLP-1 implants under development for obesity/chronic weight management and type 2 diabetes treatment, respectively.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2025Announced record date for Cortigent neuromodulation subsidiary spin-off with expected NASDAQ listing
  • May 2025Completed $3.0 million equity financing to support R&D and clinical activities
  • +1 moreTrack every material event for Vivani Medical, Inc. as it happens. Explore monitoring →
Get alerted when Vivani Medical, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ozempic/WegovyWeekly injectable GLP-1 agonist for diabetes and weight management→TrulicityWeekly injectable GLP-1 agonist for diabetes→Various long-acting GLP-1 formulationsMonthly or quarterly injectable alternatives→

Compare Vivani Medical, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Vivani Medical, Inc. operates in Biopharmaceutical/Medical Devices - Drug Delivery Systems. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biopharmaceutical by Cyborg Score

Browse Biopharmaceutical/Medical Devices - Drug Delivery Systems research →
NEW · MCP server

Ask your AI assistant about Vivani Medical, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Vivani Medical, Inc. and its top competitor on Cyborg Score”
“What did Vivani Medical, Inc. do this quarter?”
“Is Vivani Medical, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Vivani Medical, Inc. do?+
Vivani Medical is a clinical-stage biopharmaceutical company developing miniaturized and subdermal drug implants using its proprietary NanoPortal implant technology to address chronic diseases and medication non-adher...
What is Vivani Medical, Inc.'s Cyborg Score?+
Vivani Medical, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Vivani Medical, Inc.'s main competitors?+
Named competitors include Ozempic/Wegovy, Trulicity, Various long-acting GLP-1 formulations. The full competitive landscape is in the AskCyborg report.
How can I get the full Vivani Medical, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Vivani Medical, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Vivani Medical, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biopharmaceutical research

Companies in the same sector and named competitors, ranked by Cyborg Score.

9Eli Lilly and Company8argenx SE8Ascendis Pharma A/S8Avidity Biosciences, Inc.8BeOne Medicines AG8Celltrion, Inc.8Corcept Therapeutics Incorporated8Insmed Incorporated8Roivant Sciences Ltd.8Terns Pharmaceuticals, Inc.Top companies in Biopharmaceutical by Cyborg Score